This is a non-core endpoint: only basic statistics are computed.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
42 |
4. Check minimum number of eventsNone |
42 |
5. Include endpointsNone |
42 |
6. Filter based on genotype QC (FinnGen only) |
42 |
Control definitions (FinnGen only)
- Control exclude
- I9_CEREBVASC
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- I67
- Name in latin
- Morbus moyamoya
Similar endpoints
↥List of similar endpoints to
Moyamoya
based on the number of shared cases.
Similar with more cases:
- Cerebrovascular diseases
- Neurological diseases, wide definition
- Cardiovascular diseases
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 260 | 184 | 73 |
| Only index persons | 240 | 170 | 70 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.00 | 0.01 | 0.00 |
| Only index persons | 0.01 | 0.01 | 0.00 |
| Median age at first event (years) | |||
| Whole population | 43.29 | 42.88 | 44.67 |
| Only index persons | 42.72 | 41.59 | 45.44 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 42 | 30 | 12 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 40.18 | 38.03 | 45.56 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
0
+∞
7.50
2.6
0.0
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
11
19
7.49
6.48
4.0
9.3
kpa
4.9
5.3
0.50
11
19
(3027801) Oxygen [Partial pressure] in Arterial blood
11
19
7.49
6.48
4.0
9.3
kpa
17.8
13.6
0.83
11
19
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
8
9
10.63
4.50
1.3
1.4
mg/l
494.0
359.2
—
8
9
(3009445) Proteinase 3 Ab [Units/volume] in Serum
7
7
11.66
4.18
1.0
1.0
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
7
8
10.19
3.93
1.1
1.4
mmol/l
3.5
3.4
—
7
8
(3020630) Protein [Mass/volume] in Serum or Plasma
7
9
9.04
3.71
1.0
1.4
g/l
67.3
66.4
—
7
9
(3004588) Protein electrophoresis panel - Serum or Plasma
6
6
11.37
3.61
1.0
2.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
6
11.37
3.61
1.0
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
7
10
8.13
3.51
3.1
1.1
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
6
7
9.73
3.38
5.0
9.6
mmol/l
22.8
24.2
—
6
7
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
6
8
8.50
3.16
1.2
1.3
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
6
8
8.50
3.16
1.2
2.5
%
122.0
185.4
—
6
8
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
11
37
3.67
2.94
1.9
2.5
e6/l
5.9
5.1
—
6
19
(3000991) Gas panel - Venous blood
7
14
5.76
2.86
2.4
8.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
5
6
9.23
2.82
1.2
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
7
15
5.37
2.72
1.6
1.1
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
6
11
6.15
2.64
2.8
10.1
%
0.6
0.8
—
6
11
(3016502) Oxygen saturation in Arterial blood
7
16
5.02
2.60
3.3
10.1
%
98.1
94.8
—
7
16
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
20
105
2.73
2.52
3.6
2.1
ng/l
16.2
58.6
—
9
52
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
6
12
5.63
2.49
2.8
9.4
%
0.9
2.3
—
6
12
(3027944) Amphetamines [Presence] in Urine
7
18
4.44
2.37
1.4
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
7
18
4.44
2.37
1.6
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
7
18
4.44
2.37
1.6
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
7
18
4.44
2.37
1.6
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
18
94
2.60
2.24
2.4
2.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
14
65
2.73
2.18
4.5
2.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
25
155
2.51
2.16
8.8
6.2
e9/l
0.0
0.0
0.00
18
122
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
18
98
2.46
2.02
5.4
2.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
6
17
3.93
1.91
1.5
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
6
17
3.93
1.91
2.8
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
10
42
2.81
1.84
1.2
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
11
49
2.69
1.82
2.7
3.0
ng/l
79.5
182.6
—
6
28
(3005719) IgG [Mass/volume] in Serum or Plasma
6
18
3.71
1.82
1.3
2.3
g/l
8.6
10.3
—
6
18
(36304419) Bacteria [Presence] in Urine
15
79
2.40
1.78
5.8
2.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
6
19
3.50
1.73
1.3
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
5
15
3.63
1.57
1.8
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
21
137
2.07
1.44
2.9
1.8
—
—
—
0
0
(3026782) Osmolality of Urine
11
56
2.31
1.37
7.4
2.1
mosm/kgh2o
455.7
592.9
1.25
11
46
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
13
72
2.17
1.34
2.1
2.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
37
315
2.46
1.23
18.9
12.1
%
14.5
13.5
0.72
37
307
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
9
47
2.16
1.11
2.2
1.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
30
239
1.89
1.01
6.7
3.6
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
23
172
1.75
0.93
6.5
5.6
e9/l
0.2
0.2
0.84
17
161
(42870588) Differential panel, method unspecified - Blood
15
99
1.80
0.92
4.3
5.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
15
99
1.80
0.92
10.1
4.7
inr
1.1
1.1
—
6
27
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
6
32
2.02
0.85
9.2
2.8
u/l
186.7
234.7
—
6
32
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
31
256
1.81
0.85
2.7
2.6
u/l
39.0
37.6
0.06
31
249
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
25
0.00
0.82
0.0
1.4
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
5
23
2.33
0.79
2.8
8.3
mmol/l
106.4
105.1
—
5
23
(3013512) EKG study
12
78
1.75
0.76
3.8
2.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
7
41
1.85
0.74
1.9
1.6
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
15
105
1.67
0.73
2.3
2.2
nmol/l
79.6
72.7
0.41
15
93
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
35
309
1.79
0.71
6.3
4.7
mmol/mol
37.4
38.5
0.35
35
296
(3029937) Albumin [Presence] in Urine by Test strip
12
80
1.70
0.69
9.2
3.1
estimate
0.0
0.0
—
7
30
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
20
153
1.59
0.68
4.9
3.9
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
15
108
1.60
0.65
1.9
1.7
pmol/l
107.1
96.6
—
10
60
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
37
333
1.93
0.65
5.8
3.8
mu/l
1.6
1.8
0.41
37
311
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
0
21
0.00
0.62
0.0
1.6
—
1.4
—
0
13
(3022096) Basophils/100 leukocytes in Blood
19
147
1.53
0.60
5.6
4.9
%
0.6
0.6
0.07
19
136
(3023368) Bacteria identified in Blood by Culture
9
60
1.63
0.60
5.8
4.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
6
37
1.72
0.58
1.8
1.5
nmol/l
1738.8
1150.5
—
6
30
(3021960) Folate [Moles/volume] in Serum or Plasma
9
62
1.57
0.58
1.9
1.5
nmol/l
14.0
22.3
—
9
50
(3015377) Calcium [Moles/volume] in Serum or Plasma
13
93
1.58
0.57
1.8
4.8
mmol/l
2.4
2.3
0.43
13
88
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
25
290
0.66
0.56
3.9
4.0
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
15
112
1.53
0.55
2.5
2.5
u/l
20.7
27.3
1.70
15
103
(46235355) HIV 1 and 2 tests - Meaningful Use set
14
103
1.54
0.54
1.7
2.1
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
21
170
1.47
0.52
7.0
4.8
e9/l
2.0
1.9
0.09
13
158
(3042936) Bacteria identified in Isolate by Culture
7
46
1.62
0.51
1.9
2.4
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
19
151
1.47
0.51
5.5
5.1
%
2.5
2.9
0.58
19
140
(3019069) Monocytes/100 leukocytes in Blood
19
152
1.46
0.49
5.6
5.4
%
10.6
8.0
0.95
19
143
(3018010) Neutrophils/100 leukocytes in Blood
19
153
1.44
0.47
6.6
5.0
%
55.1
57.9
0.47
19
144
(3000850) Epithelial cells [#/volume] in Urine
8
58
1.47
0.45
9.1
2.0
e6/l
4.0
4.4
—
8
50
(3041096) Erythrocytes [Presence] in Urine by Automated
13
98
1.47
0.44
10.1
2.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
15
0.00
0.42
0.0
1.9
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
15
0.00
0.42
0.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
15
0.00
0.42
0.0
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
0
16
0.00
0.42
0.0
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
0
16
0.00
0.42
0.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
0
16
0.00
0.42
0.0
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
0
16
0.00
0.42
0.0
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
5
34
1.53
0.42
1.0
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
0
17
0.00
0.41
0.0
1.5
—
238.9
—
0
11
(3006315) Basophils [#/volume] in Blood
20
166
1.39
0.41
7.1
4.8
e9/l
0.0
0.0
0.04
13
150
(3001604) Monocytes [#/volume] in Blood
20
166
1.39
0.41
7.1
4.8
e9/l
0.7
0.6
0.56
13
150
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
37
342
1.69
0.40
5.1
3.9
mmol/l
4.5
4.8
1.34
37
324
(3022145) Colonoscopy Study observation
6
41
1.54
0.38
1.0
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
29
259
1.39
0.36
5.1
3.3
pmol/l
14.2
14.5
0.39
29
241
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
6
45
1.39
0.35
2.0
2.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
17
140
1.36
0.35
3.4
2.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
15
122
1.36
0.33
9.1
2.8
—
—
—
0
0
(3044889) 12 lead EKG panel
20
228
0.77
0.30
4.1
2.9
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
37
346
1.58
0.29
5.6
4.1
mmol/l
2.5
2.9
2.08
37
326
(3026493) Urate [Moles/volume] in Serum or Plasma
7
93
0.70
0.26
1.7
2.5
umol/l
57420.0
330.0
—
7
83
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
7
89
0.74
0.25
1.7
1.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
6
47
1.32
0.22
1.8
1.5
%
2.4
1.2
—
6
42
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
10.3
—
0
10
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
0
12
0.00
0.21
0.0
3.9
—
25.0
—
0
12
(3003694) ABO and Rh group [Type] in Blood
14
119
1.26
0.21
1.6
1.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
18
158
1.24
0.21
7.7
2.8
estimate
0.0
0.0
—
7
28
(3002523) Influenza virus A Ag [Presence] in Specimen
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.5
—
43.3
—
0
14
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
7
59
1.22
0.19
1.0
1.7
ng/l
301.3
450.7
—
7
52
(3021601) Nitrite [Presence] in Urine by Test strip
18
160
1.22
0.18
9.7
4.1
estimate
0.0
0.0
—
6
30
(3009542) Hematocrit [Volume Fraction] of Blood
36
341
1.39
0.17
14.8
11.4
%
39.7
40.6
0.28
31
280
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
36
341
1.39
0.17
5.3
3.8
mmol/l
1.4
1.5
0.76
36
320
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
34
323
1.28
0.16
5.1
3.5
mmol/l
1.5
1.3
0.89
34
304
(3009261) Glucose [Presence] in Urine by Test strip
18
163
1.18
0.14
7.9
3.0
estimate
0.0
0.0
—
7
24
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
10
86
1.21
0.12
1.6
1.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
21
195
1.15
0.11
8.5
7.5
e9/l
3.9
4.3
0.60
14
174
(3017143) Hepatitis C virus Ab [Presence] in Serum
6
56
1.08
0.09
1.8
1.5
—
—
—
0
0
(3015736) pH of Urine
11
122
0.87
0.08
7.1
2.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
8
89
0.88
0.07
4.3
6.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
10
91
1.13
0.05
2.1
1.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
7
72
0.97
0.00
2.7
2.3
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4211845)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
7
76
0.91
0.00
3.1
2.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
5
48
1.05
0.00
2.4
1.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
13.9
—
0
8
(3029075) Extractable nuclear Ab panel - Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
0
9
0.00
0.00
0.0
1.6
—
205.4
—
0
9
(3011397) Hemoglobin [Presence] in Urine by Test strip
6
68
0.86
0.00
1.8
3.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(4281824)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.7
—
79.2
—
0
6
(40768800) Prostate Pathology biopsy report
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
7
77
0.89
0.00
1.6
1.8
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
6
0.00
0.00
0.0
1.3
—
12.8
—
0
6
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
8
78
1.03
0.00
11.5
2.6
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
0
5
0.00
0.00
0.0
1.2
—
1.9
—
0
5
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
2.7
—
0
5
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
38.5
—
0
5
(3009466) Valproate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.0
—
324.4
—
0
5
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint I9_MOYAMO and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have I9_MOYAMO.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: I9_MOYAMO – Moyamoya
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data